Journal Information Content Entity Continuant Continuant Entity Entity Periodical Generically Dependent Continuant Collection 2025-06-26T13:06:35 RDF description of JTO Clin Res Rep - http://repository.healthpartners.com/individual/journal-JTO-Clin-Res-Rep public journal-JTO-Clin-Res-Rep JTO Clin Res Rep Phase 2 trial of nivolumab and ramucirumab for relapsed mesothelioma: HCRN-LUN15-299 Alliance Foundation Trial 09: a randomized, multicenter, phase 2 trial evaluating two sequences of pembrolizumab and standard platinum-based chemotherapy in patients with metastatic NSCLC